Holmes Scott A 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed May 16, 2018
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-05-15$5.69/sh−1,158$6,589→ 168,904 total
Footnotes (2)
- [F1]Sale of a total of 1,158 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 4,063 shares of restricted stock on May 14, 2018. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 86,872 shares of restricted stock.